384 related articles for article (PubMed ID: 16940085)
41. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.
Zarrilli R; Casillo R; Di Popolo A; Tripodi MF; Bagattini M; Cuccurullo S; Crivaro V; Ragone E; Mattei A; Galdieri N; Triassi M; Utili R
Clin Microbiol Infect; 2007 May; 13(5):481-9. PubMed ID: 17430339
[TBL] [Abstract][Full Text] [Related]
42. An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China.
Zong Z; Lü X; Valenzuela JK; Partridge SR; Iredell J
Int J Antimicrob Agents; 2008 Jan; 31(1):50-4. PubMed ID: 18077141
[TBL] [Abstract][Full Text] [Related]
43. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil.
Carvalho KR; Carvalho-Assef AP; Peirano G; Santos LC; Pereira MJ; Asensi MD
Int J Antimicrob Agents; 2009 Jul; 34(1):25-8. PubMed ID: 19216059
[TBL] [Abstract][Full Text] [Related]
44. Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals.
Bonnin RA; Poirel L; Licker M; Nordmann P
Clin Microbiol Infect; 2011 Oct; 17(10):1524-8. PubMed ID: 21883667
[TBL] [Abstract][Full Text] [Related]
45. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
[TBL] [Abstract][Full Text] [Related]
46. Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
Kouyama Y; Harada S; Ishii Y; Saga T; Yoshizumi A; Tateda K; Yamaguchi K
J Infect Chemother; 2012 Aug; 18(4):522-8. PubMed ID: 22327516
[TBL] [Abstract][Full Text] [Related]
47. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
[TBL] [Abstract][Full Text] [Related]
48. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.
Ruiz M; Marti S; Fernandez-Cuenca F; Pascual A; Vila J
Clin Microbiol Infect; 2007 Dec; 13(12):1192-8. PubMed ID: 17850347
[TBL] [Abstract][Full Text] [Related]
49. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
50. Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey.
Kulah C; Mooij MJ; Comert F; Aktas E; Celebi G; Ozlu N; Rijnsburger MC; Savelkoul PH
Int J Antimicrob Agents; 2010 Aug; 36(2):114-8. PubMed ID: 20510587
[TBL] [Abstract][Full Text] [Related]
51. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.
Ruan Z; Chen Y; Jiang Y; Zhou H; Zhou Z; Fu Y; Wang H; Wang Y; Yu Y
Int J Antimicrob Agents; 2013 Oct; 42(4):322-8. PubMed ID: 23988720
[TBL] [Abstract][Full Text] [Related]
52. Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.
Da Silva GJ; Quinteira S; Bértolo E; Sousa JC; Gallego L; Duarte A; Peixe L;
J Antimicrob Chemother; 2004 Jul; 54(1):255-8. PubMed ID: 15190040
[TBL] [Abstract][Full Text] [Related]
53. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia.
Le Hello S; Falcot V; Lacassin F; Baumann F; Nordmann P; Naas T
Clin Microbiol Infect; 2008 Oct; 14(10):977-81. PubMed ID: 18828857
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran.
Sohrabi N; Farajnia S; Akhi MT; Nahaei MR; Naghili B; Peymani A; Amiri Z; Rezaee MA; Saeedi N
Microb Drug Resist; 2012 Aug; 18(4):385-9. PubMed ID: 22352411
[TBL] [Abstract][Full Text] [Related]
55. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
[TBL] [Abstract][Full Text] [Related]
56. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia.
Naas T; Levy M; Hirschauer C; Marchandin H; Nordmann P
J Clin Microbiol; 2005 Sep; 43(9):4826-9. PubMed ID: 16145150
[TBL] [Abstract][Full Text] [Related]
57. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.
Vahaboglu H; Budak F; Kasap M; Gacar G; Torol S; Karadenizli A; Kolayli F; Eroglu C
J Antimicrob Chemother; 2006 Sep; 58(3):537-42. PubMed ID: 16816400
[TBL] [Abstract][Full Text] [Related]
58. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.
Huang L; Sun L; Xu G; Xia T
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):326-32. PubMed ID: 18687557
[TBL] [Abstract][Full Text] [Related]
59. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.
Stoeva T; Higgins PG; Bojkova K; Seifert H
Clin Microbiol Infect; 2008 Jul; 14(7):723-7. PubMed ID: 18558947
[TBL] [Abstract][Full Text] [Related]
60. Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Salehi B; Ghalavand Z; Mohammadzadeh M; Maleki DT; Kodori M; Kadkhoda H
J Appl Microbiol; 2019 Nov; 127(5):1421-1429. PubMed ID: 31400237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
